Alethea Capital Management’s Catheter Precision VTAK Stock Holding History

Alethea Capital Management’s Portfolio VTAK Stock Details VTAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1	Closed	-$1K	–	58
2022 Q3	$1K	Hold	1	–	–	﹤0.01%	58
2022 Q2	$4K	Hold	1	–	–	0.01%	64
2022 Q1	$5K	Hold	1	–	–	﹤0.01%	65
2021 Q4	$19K	Hold	1	–	–	0.02%	86
2021 Q3	$39K	Hold	1	–	–	0.03%	79
2021 Q2	$54K	Hold	1	–	–	0.03%	82
2021 Q1	$57K	Hold	1	–	–	0.03%	75
2020 Q4	$92K	Sell	1 -1	-50%	-$59.5K	0.05%	72
2020 Q3	$152K	Hold	2	–	–	0.1%	63
2020 Q2	$259K	Hold	2	–	–	0.15%	74
2020 Q1	$573K	Hold	2	–	–	0.37%	24
2019 Q4	$594K	Hold	2	–	–	0.25%	34
2019 Q3	$736K	Hold	2	–	–	0.47%	24
2019 Q2	$1.9M	Buy	2 +1	+100%	+$911K	1.24%	7
2019 Q1	$704K	Buy	+1	New	+$1.67M	0.5%	28
2018 Q4	–	Hold	0	–	–	–	20

Other funds holding VTAK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

APC

Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return

Alethea Capital Management's VTAK Position: Q4 2022 in Review

Alethea Capital Management sold out of Catheter Precision (VTAK) in Q4 2022, closing a stake of 1 share — an estimated $1K sold.

Alethea Capital Management first reported a position in VTAK in Q1 2019 and held it in 15 quarters. The position peaked at $1.9M in Q2 2019. 9 funds tracked by Wall St. Rank hold VTAK as of Q4 2022.

Alethea Capital Management reported no remaining Catheter Precision position as of Q4 2022 after selling out during the quarter.
Alethea Capital Management sold 1 Catheter Precision share in Q4 2022, an estimated $1K.
Alethea Capital Management first reported a position in Catheter Precision in Q1 2019 and held it in 15 quarters.
Alethea Capital Management's Catheter Precision position peaked at $1.9M in Q2 2019.
9 funds tracked by Wall St. Rank held Catheter Precision as of Q4 2022.

Based on Alethea Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.